中国冠心病介入治疗发展现状:质量管理

Development status of intervention therapy for coronary heart disease in China:quality control

在过去的30年中,中国冠状动脉介入治疗快速发展,介入治疗质量的提高受到越来越多的关注。在卫生行政部门主导下建立的冠心病介入治疗规范化体系,旨在对这一技术进行全流程质量管理,其中质量控制系统是最重要的手段。目前已建立国家级质控中心和省级质控中心,通过多种质控手段对医疗机构和术者的医疗质量进行监督管理,并对冠状动脉介入技术应用的整体情况进行把控。网络直报系统是质控体系的基础,减少漏报是未来质控工作的重点之一。各级质控中心通过质控培训、病例检查等多种途径促进冠状动脉介入治疗质量的提高。目前国内主要质控指标与国外基本处于同一水平。未来的质控工作将进一步加强信息化建设,围绕质控核心指标开展,以达到质控工作全覆盖的目的。

Coronary intervention therapy developed fast in past 30 years in China,meanwhile quality control became a common concern.A standardization system for coronary intervention therapy was established with domination of national health administration to implement a whole process quality management,in which quality control system was the most important part.National and provincial quality control centers supervise the performance of medical centers and operators and collect the information of coronary intervention cases by multiple means.The quality control system is based on online data reported by the medical centers,so that reducing missing data is vital for overseeing nationwide cases.Quality centers improve the quality of coronary intervention therapy by vary measures,such as training and audit.Present main quality control index are comparable with that in other countries.In the future,information construction will be strengthened,and core quality control index will be implemented in all quality control activities to reach the goal of full coverage in whole process and whole area.